Status:
COMPLETED
Use of Atropine in Tredmill Stress Testing
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Chest Pain
Eligibility:
FEMALE
18+ years
Phase:
PHASE3
Brief Summary
The aim of this study is to evaluate the Safety and feasibility of atropine added during treadmill stress testing in patients with chronotropic incompetence or poor exercise capacity. Our hypothesis ...
Eligibility Criteria
Inclusion
- Patients with chest pain without evidence of ischemia eligible for exercise test.
- Age\> 18 years old
Exclusion
- Absolute:
- Patients with LBBB
- Unstable Angina
- Recent Myocardial Infarction
- Un controlled Arrythmia
- Congestive heart faliure
- Severe symptomatic valvular heart disease
- Acute Pulmonary Embolism
- Acute perimyocarditis
- Acute aortic dissection
- Relative:
- Lt main stenosis
- Severe hypertention (Systolic\> 200 mmHg; Diastolic \> 100 mmHg)
- Cardiomyopathy
- Obstructiove abnormalities
- Psychiatric disorders
- High degree AV Block
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT00623207
Start Date
December 1 2007
End Date
October 1 2009
Last Update
July 27 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Heart Institute, Ha'Emek Medical Center
Afula, Afula, Israel, 18100